Core (required) co.paralleluniverse:quasar-core:0.8.0 Actors co.paralleluniverse:quasar-actors:0.8.0 Reactive Streams co.paralleluniverse:quasar-reactive-streams:0.8.0 Disruptor Channels ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their Meeting held today i.e. 13th August, ...

When you gaze up at the night sky, it’s easy to feel as though you're looking into an endless, empty canvas sprinkled with ...

A paternity test is pending, but Bennu and Ryugu could turn out to be long-lost twins, separated at birth by a cosmic cataclysm. New research by a University of Arizona-led team suggests the two ...

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline results expected Q1 2026. AXPAXLI™ leverages proven science and a de-risked ...